Skip to main content
Clinical Trials/JPRN-UMIN000010560
JPRN-UMIN000010560
Recruiting
未知

Research on the preventive effect of the atrial fibrillation by febuxostat - Research on the preventive effect of the atrial fibrillation by febuxostat

Cardiology, National defense medical college0 sites60 target enrollmentApril 1, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Paroxysmal atrial fibrillation
Sponsor
Cardiology, National defense medical college
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cardiology, National defense medical college

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (a) persistent and permanent AF (b) The patient who was new\-prescribed in an ACE inhibitor or ARB within six months recently. A patient who had the quantity of an ACE inhibitor or ARB increased within six months. (c) The patient who has mitral stenosis more than the degree of moderate class (d) The patient who received catheter ablation during less than three months or research period. (e) The patient already medicated with allopurinol. (f) A patient with the past of the hypersensitivity to the medicine (g)The patient who has liver disease (AST or ALT \>100U) (h)The patient who has a severe renal failure (BUN \>30mg/dL, Serum creatinin \>2\.5mg/dL) (i) The patient under administration of azathioprine, vidarabine and didanosine (contraindications) (j) A woman under pregnancy or with the possibility of pregnancy (k) The woman under breast\-feeding (l) The patient who received medication of other trial drugs within three months before the medication (m) In addition, the patient who judged that a chief (assignment) researcher was unsuitable as a subject

Outcomes

Primary Outcomes

Not specified

Similar Trials